Comment
. 2007 Sep 1;25(25):4020-1; author reply 4021-3.
doi: 10.1200/JCO.2007.11.7580.
Human epidermal growth factor receptor 2 testing recommendation
- PMID: 17761990
- DOI: 10.1200/JCO.2007.11.7580
Item in Clipboard
Comment
Human epidermal growth factor receptor 2 testing recommendation
J Clin Oncol.
.
No abstract available
Comment on
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.J Clin Oncol. 2007 Jan 1;25(1):118-45. doi: 10.1200/JCO.2006.09.2775. Epub 2006 Dec 11. J Clin Oncol. 2007. PMID: 17159189
Similar articles
-
Human epidermal growth factor receptor 2 testing in breast cancer.J Clin Oncol. 2007 Sep 1;25(25):4020; author reply 4021-3. doi: 10.1200/JCO.2007.10.8522. J Clin Oncol. 2007. PMID: 17761991 No abstract available.
-
Human epidermal growth factor receptor 2 testing in breast cancer: 30% versus 10% cutoff for immunohistochemistry.J Clin Oncol. 2008 Mar 20;26(9):1571. doi: 10.1200/JCO.2008.16.6868. J Clin Oncol. 2008. PMID: 18349417 No abstract available.
-
Current status of HER2 testing: caught between a rock and a hard place.Am J Clin Pathol. 2001 Dec;116(6):806-10. doi: 10.1309/WMN8-VTR5-DUGF-X12L. Am J Clin Pathol. 2001. PMID: 11764067 Review. No abstract available.
-
Clinical practice patterns and cost-effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients.Cancer. 2010 Aug 15;116(16):3980-1; author reply 3981. doi: 10.1002/cncr.25186. Cancer. 2010. PMID: 20564109 No abstract available.
-
[erbB2 as a prognostic factor of breast cancers].Nihon Rinsho. 2000 Apr;58 Suppl:407-12. Nihon Rinsho. 2000. PMID: 11026025 Review. Japanese. No abstract available.
Cited by
-
Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer.BMC Med Imaging. 2021 Dec 2;21(1):184. doi: 10.1186/s12880-021-00714-0. BMC Med Imaging. 2021. PMID: 34856951 Free PMC article.
-
Application of ultrasound-based radiomics models of breast masses to predict invasive components of encapsulated papillary carcinoma.Quant Imaging Med Surg. 2023 Oct 1;13(10):6887-6898. doi: 10.21037/qims-22-1069. Epub 2023 Sep 15. Quant Imaging Med Surg. 2023. PMID: 37869304 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
